Literature DB >> 14962768

DNA vaccines for allergy treatment.

Arnulf Hartl1, Richard Weiss, Romana Hochreiter, Sandra Scheiblhofer, Josef Thalhamer.   

Abstract

In the past 10 years, a great number of studies have demonstrated that injection of plasmid DNA coding for certain genes results in the induction of humoral and cellular immune responses against the respective gene product. This vaccination approach covers a broad range of possible applications, including the induction of protective immunity against viral, bacterial, and parasitic infections, and it opens new perspectives for treatment of cancer. Surprisingly, DNA immunization also turned out as a promising novel type of immunotherapy against allergy. In this paper, we describe the construction of DNA vaccines for application in allergy models. Beyond, we offer a palette of recently developed modulations to optimize DNA vaccines for allergy treatment by increasing their immunogenicity and minimizing their anaphylactic potential.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962768     DOI: 10.1016/j.ymeth.2003.08.014

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  16 in total

1.  Characterization of novel peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) isoform in human liver.

Authors:  Thomas K Felder; Selma M Soyal; Hannes Oberkofler; Penelope Hahne; Simon Auer; Richard Weiss; Gabriele Gadermaier; Karl Miller; Franz Krempler; Harald Esterbauer; Wolfgang Patsch
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

2.  Polymeric structure and host Toll-like receptor 4 dictate immunogenicity of NY-ESO-1 antigen in vivo.

Authors:  Yanan Liu; Xiaoli Tian; Wolfgang W Leitner; Michael E Aldridge; Junying Zheng; Zhiya Yu; Nicholas P Restifo; Richard Weiss; Sandra Scheiblhofer; Chong Xie; Ren Sun; Genhong Cheng; Gang Zeng
Journal:  J Biol Chem       Date:  2011-09-07       Impact factor: 5.157

3.  A mimotope gene encoding the major IgE epitope of allergen Phl p 5 for epitope-specific immunization.

Authors:  J Wallmann; M Proell; T Stepanoska; B Hantusch; I Pali-Schöll; T Thalhamer; J Thalhamer; E Jensen-Jarolim; A Hartl
Journal:  Immunol Lett       Date:  2008-12-25       Impact factor: 3.685

4.  From sequence to antibody: genetic immunisation is suitable to generate antibodies against a rare plant membrane protein, the KAT 1 channel.

Authors:  Renate Gehwolf; Richard Weiss; Maximilian Gabler; Annette C Hurst; Adam Bertl; Josef Thalhamer; Gerhard Obermeyer
Journal:  FEBS Lett       Date:  2007-01-16       Impact factor: 4.124

5.  Transcutaneous vaccination via laser microporation.

Authors:  Richard Weiss; Michael Hessenberger; Sophie Kitzmüller; Doris Bach; Esther E Weinberger; Wolf D Krautgartner; Cornelia Hauser-Kronberger; Bernard Malissen; Christof Boehler; Yogeshvar N Kalia; Josef Thalhamer; Sandra Scheiblhofer
Journal:  J Control Release       Date:  2012-06-29       Impact factor: 9.776

6.  Generation of hypoallergenic neoglycoconjugates for dendritic cell targeted vaccination: a novel tool for specific immunotherapy.

Authors:  Esther E Weinberger; Martin Himly; Julia Myschik; Michael Hauser; Friedrich Altmann; Almedina Isakovic; Sandra Scheiblhofer; Josef Thalhamer; Richard Weiss
Journal:  J Control Release       Date:  2012-11-10       Impact factor: 9.776

7.  Diclofenac hypersensitivity: antibody responses to the parent drug and relevant metabolites.

Authors:  Andrea Harrer; Roland Lang; Robert Grims; Michaela Braitsch; Thomas Hawranek; Werner Aberer; Lothar Vogel; Walther Schmid; Fatima Ferreira; Martin Himly
Journal:  PLoS One       Date:  2010-10-28       Impact factor: 3.240

8.  Pectate lyase pollen allergens: sensitization profiles and cross-reactivity pattern.

Authors:  Ulrike Pichler; Michael Hauser; Martin Wolf; Maria Livia Bernardi; Gabriele Gadermaier; Richard Weiss; Christof Ebner; Hidenori Yokoi; Toshiro Takai; Alain Didierlaurent; Chiara Rafaiani; Peter Briza; Adriano Mari; Heidrun Behrendt; Michael Wallner; Fátima Ferreira
Journal:  PLoS One       Date:  2015-05-15       Impact factor: 3.240

9.  Transcutaneous immunotherapy via laser-generated micropores efficiently alleviates allergic asthma in Phl p 5-sensitized mice.

Authors:  D Bach; R Weiss; M Hessenberger; S Kitzmueller; E E Weinberger; W D Krautgartner; C Hauser-Kronberger; C Boehler; J Thalhamer; S Scheiblhofer
Journal:  Allergy       Date:  2012-09-05       Impact factor: 13.146

10.  Prophylactic mRNA Vaccination against Allergy Confers Long-Term Memory Responses and Persistent Protection in Mice.

Authors:  E Hattinger; S Scheiblhofer; E Roesler; T Thalhamer; J Thalhamer; R Weiss
Journal:  J Immunol Res       Date:  2015-10-18       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.